Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
21 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/henlius-and-intas-receive-positive-chmp-opinion-for-hetronifly-approved-as-hansizhuang-in-china-in-european-markets-as-first-line-treatment-for-adult-patients-with-extensive-stage-small-cell-lung-cancer-302254345.html
24 May 2024
// BUSINESSWIRE
17 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/henlius-releases-2023-esg-report-pursuing-sustainable-development-with-patient-centricity-302119490.html
04 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/henlius-forecasts-profit-in-2023-achieving-first-full-year-of-profitability-and-ushering-in-a-new-phase-of-high-quality-development-302078510.html
12 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-nda-for-new-indication-of-henlius-anti-pd-1-mab-serplulimab-in-combination-with-chemotherapy-for-the-first-line-treatment-of-non-squamous-nsclc-accepted-by-the-nmpa-302012575.html
15 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/henlius-reported-financial-results-for-the-first-three-quarters-of-2023-total-revenue-exceeded-rmb3-9-billion-profitability-further-improved-301989017.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?